Search

Objective: To analyze the gender differences of genetic etiology in the incidence of major depression disorder among Han freshmen. Methods: A 1-year follow-up survey was carried out among 8 079 Han freshmen from Jining, Rizhao and Weifang without lifetime major depressive disorder (MDD) at baseline (April to October 2018) and 4 828 venous blood samples were also collected. After extracting DNA, Sequenom Mass Array time-of-flight mass spectrometry biochip technology was used to detect the genotypes of 17 single nucleotide polymorphisms (SNPs) MDD-related loci. Logistic regression was used for univariate analysis. Generalized multifactor dimension reduction was used to analyze gene-gene interactions. Composite International Diagnostic Interview (CIDI) 3.0 was used for MDD diagnosis. Results: The 1-year incidence of MDD among Han freshmen was 2.23% (95% CI : 1.91%-2.60%) and the gender difference of incidence between males (1.97%, 95% CI : 1.52%-2.56%) and females (2.39%, 95% CI : 1.98%-2.90%) was not statistically significant ( P >0.05). AG genotype of rs768705 (nearby gene: TMEM161B) was a risk factor for MDD ( OR =1.98, 95% CI : 1.24-2.83). The TC genotype of rs17727765 (nearby gene: CRYBA1) was only a risk factor for MDD in males ( OR =9.61, 95% CI : 2.04-45.30). An 8-loci interaction model (PMFBP1, OLFM4, LHPP, ENOX1, TMEM161B, SPPL3, FBXL4 and L3MBTL2) could predict MDD in women with an accuracy rate of 60.05%. No effective prediction model was found for MDD in men. Conclusions: There might be gender differences in the genetic etiology of MDD. Further researches on the genetic causes of MDD in men should be explored.

Objective: To analyze the concordance of KRAS, NRAS, BRAF and PIK3CA gene mutations detected in plasma and matched tumor tissues in colorectal cancer patients, in order to provide good evidences to support plasma could be a potential surrogate of tumor tissue for gene mutation test. Methods: One hundred and seventy-five cases of colorectal cancer were collected at the First Hospital of Jilin University, from October 2016 to October 2017.There were 101 males and 74 females, their ages ranged from 28 to 85 years,with median age of 59 years. The KRAS, NRAS, BRAF and PIK3CA gene mutations in the plasma and paired tumor specimens of all patients were detected by next generation sequencing. Results: The results of tissue samples test were gold standard. Comparison of the four genes showed that concordance rates between plasma and tissue samples were 81.1%(Kappa=0.543), 99.4%(Kappa=0.886), 99.4% (Kappa=0.886) and 97.7%(Kappa=0.714) respectively for KRAS, NRAS, BRAF and PIK3CA. The plasma detection rates of these genes were related to tumor stage( P= 0.001), but not to gender( P= 0.468) and age( P= 1.000) of patients. Conclusions: The study shows a high concordance of KRAS, NRAS, BRAF and PIK3CA gene mutations in plasma against mutation status in tumor tissue. In colorectal cancer, tumor tissue remains the best specimen for gene detection. However, patients from tumor tissue specimens cannot be obtained, especially those with advanced metastases, plasma can be used instead of tissue to detect the mutation status of KRAS, NRAS, BRAF and PIK3CA to guide targeted therapy.

Objective: To evaluate the relationship between FHIT gene and gastrointestinal cancers., Methods: Matched normal and cancerous tissues from 26 patients with primary gastric carcinoma and 30 patients with colorectal carcinoma were analysed by nested polymerase chain reaction(RT-PCR) and direct sequencing of the products., Results: Seven of 26(26.9%) gastric cancer tissues and eight of 30(26.7%) colorectal cancer tissues expressed aberrant FHIT transcripts, but no aberrant FHIT transcript was observed in all the matched normal tissues. Sequence analysis of the aberrant transcripts of 2 gastric cancer tissues(G8T, G25T) and 2 colorectal cancer tissues(C5T, C26T) confirmed the absence of 1 to 3 exons of FHIT gene., Conclusions: The expression of aberrant FHIT transcripts is common and tumor-specific in gastrointestinal cancers and abnormalities of FHIT gene may be associated with gastrointestinal tumorigenesis.

Objective: To evaluate the anti-cancer effect of Ailing-1 on human megakaryoblastic leukemia cells in culture., Methods: Using living cell counting, 3H-TdR incorporation and clonal proliferation assay., Results: Ailing-1 has various cytotoxicity on cell level, DNA synthesis and clone proliferation and shows good does-effect relation. The ED50 of Ailing-1 is greater than that of homoharringtonine through three different methods, consistent with the clinical result. Drug resistance has not been found., Conclusion: Ailing-1 is a promising anti-tumor drug.